●MycoMagic brand new Reishimmune® Ganoderma microsporum globulin-like protein concentrate (GMI) is the first commercialized fungal immunomodulatory protein (FIP) with many patents and supportive scientific studies.
●GMI has been shown to alleviate COVID-19 infection and the potential severe cases led by the cytokine storm. This work won a gold medal in the Moscow International Salon of Industrial Property “Archimedes” this year.
●USFDA NDI #1133.
●Recognized as food ingredient by TFDA in 2022.